Моше Инбар

Professor Moshe Inbar

Email to Professor Moshe Inbar


Director of the Division of Oncology at the Ichilov Medical Center. World-renowned oncologist.


  • Cancer treatment. Specializes in adenocarcinoma treatment. Develops, implements and uses innovative cancer treatment methods including immunotherapy and targeted therapy. Treats every patient according to a personalized protocol developed in conformity with the unique tumor characteristics.

Diseases Treated by the Physician:




Tel Aviv State University, Professor, Faculty of Medicine

Head of Oncology Department, Ikhilov Medical Centre

Head of the Chemotherapy Department, Ikhilov Medical Centre

Центр онкологии Слоан Кеттеринг

Sloan-Kettering Memorial Oncology Centre in New York (USA), Research Fellow

Head of the Oncology Department, Ikhilov Medical Centre

Anderson Hospital in Houston (USA). Anderson Hospital in Houston (USA), Research Associate

Private practice at Top Ichilov Medical Centre

Senior Deputy Head of the Oncology Department, Ikhilov Medical Centre

Chief Physician, Department of Oncology, Ihilov Medical Centre

Королевский госпиталь Марсдена

Royal Marsden Hospital in London (England), specialising in radiotherapy

Научно исследовательский Институт иммуногенетики при госпитале Paul Brousse

Research Institute of Immunogenetics at the Paul Brousse Hospital in Villejuivet (France), specialising in oncology

Ikhilov Medical Centre, specialising in oncology

Jerusalem State University, Faculty of Medicine


Israeli Breast Cancer Group (IBCG) – Chairman (former)

Израильское общество онкологии и радиотерапии

Israeli Society for Clinical Oncology and Radiation Therapy – President (former)

Commission for the certification of oncologists

Deputy Chairman of the examination board for certification in oncology


Israeli Association of Oncology and Radiotherapy – President (former)


European Society for Medical Oncology (ESMO)

European Society for Medical Oncology (ESMO)


European Society of Breast Cancer Specialists (EUSOMA)

  • Breast cancer;
  • Stomach cancer;
  • Rectal cancer;
  • Esophageal cancer;
  • Prostate cancer;
  • Ovarian cancer.

In some of his scientific papers, the professor explores the combined use of the biological drug bevacizumab and chemotherapy drugs in HER2-negative, locally advanced or metastatic breast cancer.

The problem of early breast cancer diagnosis is addressed in his work “PET in Women with High Risk for Breast or Ovarian Cancer” co-authored with Professor Einat Even-Sapir, leading Israeli specialist in nuclear medicine.

проф моше инбар израиль
Prof. Moshe Inbar, Israeli oncologist

The professor emphasizes the importance of preserving high quality of life for cancer patients. In the article “Sexy Cancer – Sexuality for Cancer Patients” he presents physicians with a range of problems essential for cancer patients and their partners from diagnosis into all stages of treatment.

Professor Inbar’s research interests also include stage 4 ovarian cancer therapy. This topic is addressed in the study “Combined Weekly Carboplatin and Paclitaxel as Primary Treatment of Advanced Epithelial Ovarian Carcinoma”.

A separate study is devoted to the results of organ-preserving surgery for breast cancer with subsequent radiation therapy and treatment with hormone therapy drug tamoxifen.

моше инбар топ ихилов
Professor Moshe Inbar receives patients in Top Ichilov

Professor Inbar participates in the study of brachytherapy for prostate cancer. The results of this study were published in the article “Brachytherapy Combined with External Beam Radiation in Localized Prostate Cancer”.

Up until recently, Professor Inbar was Head of the Israeli Central Committee for Certification of Cancer Specialists. He was also in charge of the Israeli Breast Cancer Group (IBCG) and Israel Cancer Association (ICA).

Skip to content